Vontobel Holding
TEVA icon

Vontobel Holding’s Teva Pharmaceuticals TEVA Stock Holding History

Vontobel Holding’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
497,461
+52,769
+12% +$1.7M 0.05% 230
2025
Q4 		$13.9M Sell
444,692
-280,258
-39% -$6.9M 0.04% 249
2025
Q3 		$14.6M Buy
724,950
+5,274
+0.7% +$92.6K 0.04% 224
2025
Q2 		$12.1M Buy
719,676
+37,455
+5% +$604K 0.04% 237
2025
Q1 		$10.5M Sell
682,221
-5,040
-0.7% -$90K 0.04% 225
2024
Q4 		$15.1M Buy
687,261
+58,772
+9% +$1.07M 0.05% 184
2024
Q3 		$11.3M Sell
628,489
-332,717
-35% -$5.82M 0.04% 212
2024
Q2 		$15.6M Sell
961,206
-126,361
-12% -$1.95M 0.05% 178
2024
Q1 		$15.3M Sell
1,087,567
-224,567
-17% -$2.83M 0.12% 163
2023
Q4 		$13.7M Sell
1,312,134
-22,084
-2% -$206K 0.11% 171
2023
Q3 		$13.6M Sell
1,334,218
-57,602
-4% -$536K 0.13% 168
2023
Q2 		$10.5M Sell
1,391,820
-149,186
-10% -$1.21M 0.09% 202
2023
Q1 		$13.6M Sell
1,541,006
-94,379
-6% -$933K 0.13% 168
2022
Q4 		$15M Buy
1,635,385
+236,216
+17% +$2.06M 0.15% 152
2022
Q3 		$11.3M Sell
1,399,169
-547,043
-28% -$4.84M 0.13% 153
2022
Q2 		$15.5M Buy
1,946,212
+443,186
+29% +$3.86M 0.17% 134
2022
Q1 		$14.1M Sell
1,503,026
-126,953
-8% -$1.06M 0.12% 150
2021
Q4 		$12.9M Buy
1,629,979
+160,709
+11% +$1.45M 0.11% 163
2021
Q3 		$14.3M Sell
1,469,270
-98,055
-6% -$918K 0.13% 145
2021
Q2 		$15.7M Sell
1,567,325
-1,156,397
-42% -$12.2M 0.14% 135
2021
Q1 		$31.4M Sell
2,723,722
-352,855
-11% -$4.05M 0.23% 63
2020
Q4 		$39.1M Buy
+3,076,577
New +$29.5M 0.26% 55

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vontobel Holding's TEVA Position: Q1 2026 in Review

Vontobel Holding increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q1 2026, buying an estimated $1.7M and bringing the position to 497,461 shares worth $15M. The position accounts for 0.05% of the portfolio, ranked #230.

Vontobel Holding first reported a position in TEVA in Q4 2020 and has held it in 22 quarters since. The position peaked at $39.1M in Q4 2020. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Vontobel Holding held 497,461 shares of Teva Pharmaceuticals worth $15M as of Q1 2026.
  • Vontobel Holding bought 52,769 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.7M.
  • Teva Pharmaceuticals made up 0.05% of Vontobel Holding's portfolio in Q1 2026, its #230 holding.
  • Vontobel Holding first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Teva Pharmaceuticals position peaked at $39.1M in Q4 2020.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.